PGEN: Precigen Inc Kompaniya qiymatining sof foydaga nisbati
Precigen, Inc. (PGEN) aksiyalarining tebranishlari, narx-foyda koeffitsiyenti dinamikasi bilan tasdiqlanganidek, nufuzli genetiklarning ulkan ishlanmalari bilan bog'liqdir. Barqarorlik terapiyalarning tijoratlashtirilishini tezlashtirish uchun rahbariyat tomonidan mablag'larning mahorat bilan taqsimlanishi orqali ta'minlanmoqda. Shu bilan birga, qat'iy tejamkorlik va R&D sinovlariga e'tibor xatarlarni yumshatadi. 69.20 ko'rsatkichi bugungi metrika qiymatini ifodalab, investorlarning kompaniyaning kelajakdagi daromadlarini sotib olishga bo'lgan joriy xohishini belgilaydi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_PGEN_-_Precigen-Inc._-_PE-Multiple "PGEN: Precigen, Inc. Biznesning o‘zini qoplash muddati 04.07.2022 - 12.11.2026 | 👁️GURU.Markets👁️")
Intrexon (PGEN) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Precigen, Inc.|PGEN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Precigen Corp|PGEN - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Precigen, Inc.|PGEN - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Precigen|Kritik likvidlik koeffitsiyenti precigen.com
- foyda va bozor multiplikatorlari tafsilotlari:
PGEN - Kompaniyaning sof foydasi|Kutilayotgan sof daromad Precigen, Inc.|PGEN - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Precigen Inc|PGEN - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Precigen, Inc.|PGEN - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Precigen|PGEN - Bir aksiya uchun sof foyda (EPS TTM)|Sirpanuvchi yil uchun bir aksiya uchun sof foyda o'sishi precigen.com|PGEN - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Precigen, Inc.
Kompaniyaning har tomonlama tahlili:precigen.com PGEN
P/E koeffitsiyenti sof foydaning bir birligining bozor qiymatini belgilaydi va investorlarning kelajakdagi biznes o'sishi uchun qo'shimcha to'lov qilishga tayyorligini aks ettiradi. Precigen, Inc. (PGEN) holatida, kompaniyaning choraklik P/E koeffitsiyenti FDA ning qat'iy tekshiruvlari sharoitida bozor uning patentlangan saraton hujayralari terapiyasi texnologiyalari potensialini qanday baholashini ko'rsatadi, bu esa aktivlarning haddan tashqari yuqori baholanishini yoki uning innovatsion ustunliklarining yetarlicha baholanmaganligini o'z vaqtida aniqlash imkonini beradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|ABCL - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati TRML|Pharming Group N.V. (PHAR) - Narxning foydaga nisbati|nektar.com - Kompaniya qiymatining sof foydaga nisbati|UPB (Upstream Bio) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Zenas Bio ZBIO|P/E multiplikatori IMNM|Narx-foyda koeffitsiyenti Gossamer Bio Corp. GOSS|P/E multiplikatori KALV (KalVista Pharmaceuticals)|Biznesning o‘zini qoplash muddati septerna.com (SEPN)|Pieris Pharmaceuticals, Inc. - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Savara Inc (SVRA)|RIGL: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati AnaptysBio Inc. (ANAB)|Narxning foydaga nisbati Astria Therapeutics|Narx-foyda multiplikatori ENGN (engene.com)|Narx-foyda koeffitsiyenti RAPT (RAPT Therapeutics)|JBIO (aerovatetx.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ACRS (Aclaris)|Biznesning o‘zini qoplash muddati Kyverna Therapeutics, Inc (KYTX)|TLSA - Narxning foydaga nisbati|CABA (cabalettabio.com) - Narx-foyda multiplikatori|VTYX: P/E multiplikatori|Narx-foyda koeffitsiyenti Theratechnologies, Inc.|Narx-foyda koeffitsiyenti AVTX|Eledon Pharmaceuticals, Inc (ELDN) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Agenus (AGEN)|CLYM: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori ZURA (Zura Bio)|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti aTyr Pharma Inc|Adagene Corp - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati ImageneBio Inc|shattucklabs.com (STTK) - Narxning foydaga nisbati|Narx-foyda multiplikatori EQ|Narxning foydaga nisbati Connect Biopharma Holdings|Immunic Inc - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori ATRA|IFRX (inflarx.de) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori XFOR (X4 Pharmaceuticals)|P/E multiplikatori Adicet Bio Inc. ACET|CELU - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati INMB (INmune Bio Inc)|Barinthus Bio (BRNS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Kezar Life Sciences Inc|SABS (SAB Biotherapeutics) - P/E multiplikatori|P/E multiplikatori akaritx.com|Narx-foyda koeffitsiyenti ENLV (Enlivex Therapeutics)|QTTB (q32bio.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori GOVX (GeoVax Labs Inc)|Biznesning o‘zini qoplash muddati Edesa Biotech Corp (EDSA)|IBIO - Narxning foydaga nisbati|Carisma Therapeutics (CARM) - Narx-foyda koeffitsiyenti|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Bolt Biotherapeutics, Inc.|Narx-foyda koeffitsiyenti HCWB|P/E multiplikatori Aptevo|Narxning foydaga nisbati AIM ImmunoTech Inc. (AIM)|aditxt.com - Narx-foyda multiplikatori|P/E multiplikatori GRI (GRI Bio)|XORTX Therapeutics Inc (XRTX) - Kapitalizatsiyaning foydaga nisbati|HIND - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati REVB|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|scinai.com - Kompaniya qiymatining sof foydaga nisbati|CALI (CalciMedica Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Affimed Therapeutics AFMD|P/E multiplikatori ALLK|Narx-foyda koeffitsiyenti hookipapharma.com HOOK|P/E multiplikatori IGMS (IGM Biosciences)|Biznesning o‘zini qoplash muddati iteostherapeutics.com (ITOS)|Ocean Biomedical - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti TC BioPharm (Holdings) Plc (TCBP)|THRD: P/E multiplikatori
